Janus International Group, Inc. JBI 深 沪
已收盘 02-06 16:00:00 美东时间
7.27
+0.360
+5.21%
华盛通- 最 高7.34
- 今 开6.99
- 成交量 108.06万股
- 最 低 6.99
- 昨 收 6.91
- 总市值 10.09亿
- 52周最高 10.80
- 市盈率 静 14.95
- 换手率 0.78%
- 52周最低 5.725
- 委 比 -4.76%
- 总股本 1.39亿
- 历史最高 15.94
- 量 比 0.71
- 振 幅 5.07%
- 历史最低 5.725
- 每 手 1
- 风险率 1.37%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Janus International Group Acquires Kiwi II Construction For ~$97.2M In Cash
Janus International Group, Inc. (NYSE:JBI) ("Janus" or the "Company"), a leading provider of building product solutions and cutting-edge access control technologies for the self-storage and other commercial and
01-09 05:15
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 10:22
电话会总结 ｜ Janus International (JBI) Earnings Transcript
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Janus International (JBI) 2025年第三季度业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** - 第三季度总营收2.193亿美元，同比下降4.7% - 营收下降中约60%来自价格因素，40%来自销量变化 - 自储存业务营收增长3.7%，其中新建项目增长5.5%，R3渠道增长0.7% - 国际业务营收2,830万美元，同比大幅增长32.9% - 商业及其他业务营收下降20.1%，主要受TMC业务项目时间安排影响 **盈利能力：** - 调整后EBITDA为4,360万美元，同比增长1.2% -
2025-11-07 12:32
Janus International Group shares are trading lower after the company reported worse-than-expected Q3 financial results and cut its FY25 sales guidance below estimates.
Janus International Group shares are trading lower after the company reported w...
2025-11-07 00:29
Janus Intl Gr Narrows FY2025 Sales Guidance from $860.000M-$890.000M to $870.000M-$880.000M vs $883.993M Est
Janus Intl Gr (NYSE:JBI) narrows FY2025 sales outlook from $860.000 million-$890.000 million to $870.000 million-$880.000 million vs $883.993 million estimate.
2025-11-06 19:57
Janus International Earns S&P Credit Upgrade To 'BB-' On Strong Balance Sheet And Low Leverage
Janus International Group, Inc. (NYSE:JBI) ("Janus" or the "Company"), a leading provider of cutting-edge access control technologies and building product solutions for the self-storage and other commercial and
2025-10-20 19:01
美股大行评级 | 潜在涨幅166.67%！美银证券上调Rocket Pharmaceuticals目标价至10美元，评级升至"买入"
今日重点评级关注：美银证券：上调Rocket Pharmaceuticals评级至"买入"，目标价从4美元升至10美元；花旗：维持小鹏汽车"买入"评级，目标价从29美元升至29.4美元
2025-08-21 19:00
Janus International Appoints New Audit Committee Chair
Janus International Group ( ($JBI) ) has issued an update. On August 19, 2025, ...
2025-08-21 05:27
Jefferies Maintains Hold on Janus Intl Gr, Raises Price Target to $10
Jefferies analyst Philip Ng maintains Janus Intl Gr (NYSE:JBI) with a Hold and raises the price target from $9 to $10.
2025-08-21 03:06
